194 related articles for article (PubMed ID: 38291479)
1. Circulating vitamin D level before initiating chemotherapy impacts on the time-to-outcome in metastatic colorectal cancer patients: systematic review and meta-analysis.
Ottaiano A; Iacovino ML; Santorsola M; Facchini S; Iervolino D; Perri F; Nasti G; Quagliariello V; Maurea N; Ronchi A; Facchini BA; Bignucolo A; Berretta M
J Transl Med; 2024 Jan; 22(1):119. PubMed ID: 38291479
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Circulating Vitamin D Level and Its Impact on Mortality and Recurrence in Stage III Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Ottaiano A; Facchini S; Santorsola M; Nasti G; Facchini G; Montella L; Maurea N; Cascella M; Iervolino D; Facchini BA; Montopoli M; Consolo P; Quagliariello V; Rinaldi L; Berretta M
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296974
[TBL] [Abstract][Full Text] [Related]
4. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.
Ng K; Nimeiri HS; McCleary NJ; Abrams TA; Yurgelun MB; Cleary JM; Rubinson DA; Schrag D; Miksad R; Bullock AJ; Allen J; Zuckerman D; Chan E; Chan JA; Wolpin BM; Constantine M; Weckstein DJ; Faggen MA; Thomas CA; Kournioti C; Yuan C; Ganser C; Wilkinson B; Mackintosh C; Zheng H; Hollis BW; Meyerhardt JA; Fuchs CS
JAMA; 2019 Apr; 321(14):1370-1379. PubMed ID: 30964527
[TBL] [Abstract][Full Text] [Related]
5. The effect of vitamin D supplementation on survival in patients with colorectal cancer: systematic review and meta-analysis of randomised controlled trials.
Vaughan-Shaw PG; Buijs LF; Blackmur JP; Theodoratou E; Zgaga L; Din FVN; Farrington SM; Dunlop MG
Br J Cancer; 2020 Nov; 123(11):1705-1712. PubMed ID: 32929196
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer.
Chan DLH; Segelov E; Wong RS; Smith A; Herbertson RA; Li BT; Tebbutt N; Price T; Pavlakis N
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007047. PubMed ID: 28654140
[TBL] [Abstract][Full Text] [Related]
7. Oral versus intravenous fluoropyrimidines for colorectal cancer.
Chionh F; Lau D; Yeung Y; Price T; Tebbutt N
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008398. PubMed ID: 28752564
[TBL] [Abstract][Full Text] [Related]
8. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
[No Abstract] [Full Text] [Related]
9. No survival benefit from adding cetuximab or panitumumab to oxaliplatin-based chemotherapy in the first-line treatment of metastatic colorectal cancer in KRAS wild type patients: a meta-analysis.
Zhou SW; Huang YY; Wei Y; Jiang ZM; Zhang YD; Yang Q; Xie DR
PLoS One; 2012; 7(11):e50925. PubMed ID: 23226426
[TBL] [Abstract][Full Text] [Related]
10. Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer.
Claassen YH; van der Valk MJ; Breugom AJ; Frouws MA; Bastiaannet E; Liefers GJ; van de Velde CJ; Kapiteijn E
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012326. PubMed ID: 30480771
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of p53 mutations in metastatic colorectal cancer: A systematic review and meta-analysis.
Ottaiano A; Santorsola M; Capuozzo M; Perri F; Circelli L; Cascella M; Ianniello M; Sabbatino F; Granata V; Izzo F; Iervolino D; Casillo M; Petrillo N; Gualillo O; Nasti G; Savarese G
Crit Rev Oncol Hematol; 2023 Jun; 186():104018. PubMed ID: 37150312
[TBL] [Abstract][Full Text] [Related]
12. Association of Cyclin-Dependent Kinases 4 and 6 Inhibitors With Survival in Patients With Hormone Receptor-Positive Metastatic Breast Cancer: A Systematic Review and Meta-analysis.
Li J; Huo X; Zhao F; Ren D; Ahmad R; Yuan X; Du F; Zhao J
JAMA Netw Open; 2020 Oct; 3(10):e2020312. PubMed ID: 33048129
[TBL] [Abstract][Full Text] [Related]
13. Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance).
Yuan C; Sato K; Hollis BW; Zhang S; Niedzwiecki D; Ou FS; Chang IW; O'Neil BH; Innocenti F; Lenz HJ; Blanke CD; Goldberg RM; Venook AP; Mayer RJ; Fuchs CS; Meyerhardt JA; Ng K
Clin Cancer Res; 2019 Dec; 25(24):7497-7505. PubMed ID: 31548349
[TBL] [Abstract][Full Text] [Related]
14. Association between Blood 25-Hydroxyvitamin D Levels and Survival in Colorectal Cancer Patients: An Updated Systematic Review and Meta-Analysis.
Maalmi H; Walter V; Jansen L; Boakye D; Schöttker B; Hoffmeister M; Brenner H
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30011816
[TBL] [Abstract][Full Text] [Related]
15. Additively protective effects of vitamin D and calcium against colorectal adenoma incidence, malignant transformation and progression: A systematic review and meta-analysis.
Huang D; Lei S; Wu Y; Weng M; Zhou Y; Xu J; Xia D; Xu E; Lai M; Zhang H
Clin Nutr; 2020 Aug; 39(8):2525-2538. PubMed ID: 31784301
[TBL] [Abstract][Full Text] [Related]
16. Effects of Circulating 25(OH)D Status in Advanced Colorectal Cancer Patients Undergoing Chemotherapy: A Systematic Review.
Zeng X; Zhang L; Jia S; Lin T; Liu G; Yue J; Huang X
Anticancer Res; 2021 Dec; 41(12):5903-5912. PubMed ID: 34848444
[TBL] [Abstract][Full Text] [Related]
17. Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer.
Zeichner SB; Koru-Sengul T; Shah N; Liu Q; Markward NJ; Montero AJ; Glück S; Silva O; Ahn ER
Clin Breast Cancer; 2015 Feb; 15(1):e1-11. PubMed ID: 25241299
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and toxicity of adding cetuximab to chemotherapy in the treatment of metastatic colorectal cancer: a meta-analysis from 12 randomized controlled trials.
Lv ZC; Ning JY; Chen HB
Tumour Biol; 2014 Dec; 35(12):11741-50. PubMed ID: 25417200
[TBL] [Abstract][Full Text] [Related]
19. Second-line systemic therapy for metastatic colorectal cancer.
Mocellin S; Baretta Z; Roqué I Figuls M; Solà I; Martin-Richard M; Hallum S; Bonfill Cosp X
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006875. PubMed ID: 28128439
[TBL] [Abstract][Full Text] [Related]
20. Peri-operative chemotherapy for resectable colorectal lung metastasis: a systematic review and meta-analysis.
Li Y; Qin Y
J Cancer Res Clin Oncol; 2020 Mar; 146(3):545-553. PubMed ID: 32036456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
